etravirine
etravirine is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including etravirine, Intelence, Etravirine. Available dosage form: tablet.
Drug Details
- Generic Name
- etravirine
- Brand Names
- etravirine, Intelence, Etravirine
- Application Number
- ANDA219152
- Sponsor
- Bionpharma Inc.
- NDC Codes
- 12
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- ETRAVIRINE
Indications and Usage
1 INDICATIONS AND USAGE Etravirine, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients and pediatric patients 2 years of age and older [see Microbiology (12.4) and Clinical Studies (14) ] Etravirine is a human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for treatment of HIV-1 infection in treatment-experienced patients 2 years of age and older. (1)